Townsend Richard Nolan
SEC insider (Form 3/4/5 filer). CIK 0001995218. Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO). 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies Townsend Richard Nolan has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Director, Officer, Chief Executive Officer
Townsend Richard Nolan
CIK: 0001995218
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lexeo Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 24, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
145.5K shares- - Sep 14, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect2.3K shares at avg. $2.64$6K - Aug 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect3.3K shares at avg. $4.95$17K - Jul 1, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect25.9K shares at avg. $4.48$116K - Jun 29, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect67K shares- - May 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect3.3K shares at avg. $5.06$17K - Apr 6, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect55K shares at avg. $5.69$313K - Mar 13, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect2.6K shares at avg. $2.64$7K - Feb 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect10.2K shares at avg. $6.38$65K - Feb 4, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect161.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 145,500 | - | - | Direct |
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 2,306 | $2.64 | $6,097 | Direct |
| Aug 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 3,345 | $4.95 | $16,562 | Direct |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 25,947 | $4.48 | $116,243 | Direct |
| Jun 29, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 67,000 | - | $0 | Direct |
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 3,342 | $5.06 | $16,927 | Direct |
| Apr 6, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 55,000 | $5.69 | $313,137 | Direct |
| Mar 13, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 2,623 | $2.64 | $6,935 | Direct |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 10,173 | $6.38 | $64,924 | Direct |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 161,665 | - | $0 | Direct |
1-10 of 29 transactions